These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 33712071)

  • 1. Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer's disease: a systematic review and meta-analysis.
    Ding X; Zhang S; Jiang L; Wang L; Li T; Lei P
    Transl Neurodegener; 2021 Mar; 10(1):10. PubMed ID: 33712071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome.
    Tatebe H; Kasai T; Ohmichi T; Kishi Y; Kakeya T; Waragai M; Kondo M; Allsop D; Tokuda T
    Mol Neurodegener; 2017 Sep; 12(1):63. PubMed ID: 28866979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.
    Ashton NJ; Pascoal TA; Karikari TK; Benedet AL; Lantero-Rodriguez J; Brinkmalm G; Snellman A; Schöll M; Troakes C; Hye A; Gauthier S; Vanmechelen E; Zetterberg H; Rosa-Neto P; Blennow K
    Acta Neuropathol; 2021 May; 141(5):709-724. PubMed ID: 33585983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.
    Koychev I; Jansen K; Dette A; Shi L; Holling H
    J Alzheimers Dis; 2021; 79(1):177-195. PubMed ID: 33252080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.
    Thijssen EH; La Joie R; Wolf A; Strom A; Wang P; Iaccarino L; Bourakova V; Cobigo Y; Heuer H; Spina S; VandeVrede L; Chai X; Proctor NK; Airey DC; Shcherbinin S; Duggan Evans C; Sims JR; Zetterberg H; Blennow K; Karydas AM; Teunissen CE; Kramer JH; Grinberg LT; Seeley WW; Rosen H; Boeve BF; Miller BL; Rabinovici GD; Dage JL; Rojas JC; Boxer AL;
    Nat Med; 2020 Mar; 26(3):387-397. PubMed ID: 32123386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
    Thijssen EH; La Joie R; Strom A; Fonseca C; Iaccarino L; Wolf A; Spina S; Allen IE; Cobigo Y; Heuer H; VandeVrede L; Proctor NK; Lago AL; Baker S; Sivasankaran R; Kieloch A; Kinhikar A; Yu L; Valentin MA; Jeromin A; Zetterberg H; Hansson O; Mattsson-Carlgren N; Graham D; Blennow K; Kramer JH; Grinberg LT; Seeley WW; Rosen H; Boeve BF; Miller BL; Teunissen CE; Rabinovici GD; Rojas JC; Dage JL; Boxer AL;
    Lancet Neurol; 2021 Sep; 20(9):739-752. PubMed ID: 34418401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Introduction to Ultrasensitive Assays for Plasma Tau Detection.
    Ding XL; Tuo QZ; Lei P
    J Alzheimers Dis; 2021; 80(4):1353-1362. PubMed ID: 33682718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes.
    Mielke MM; Frank RD; Dage JL; Jeromin A; Ashton NJ; Blennow K; Karikari TK; Vanmechelen E; Zetterberg H; Algeciras-Schimnich A; Knopman DS; Lowe V; Bu G; Vemuri P; Graff-Radford J; Jack CR; Petersen RC
    JAMA Neurol; 2021 Sep; 78(9):1108-1117. PubMed ID: 34309632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease.
    Yang CC; Chiu MJ; Chen TF; Chang HL; Liu BH; Yang SY
    J Alzheimers Dis; 2018; 61(4):1323-1332. PubMed ID: 29376870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer's Disease Continuum.
    Coomans EM; Verberk IMW; Ossenkoppele R; Verfaillie SCJ; Visser D; Gouda M; Tuncel H; Wolters EE; Timmers T; Windhorst AD; Golla SSV; Scheltens P; van WM; Flier D; van Berckel BNM; Teunissen CE
    J Nucl Med; 2023 Mar; 64(3):437-443. PubMed ID: 36229187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease.
    Startin CM; Ashton NJ; Hamburg S; Hithersay R; Wiseman FK; Mok KY; Hardy J; Lleó A; Lovestone S; Parnetti L; Zetterberg H; Hye A; ; Strydom A
    Alzheimers Res Ther; 2019 Mar; 11(1):26. PubMed ID: 30902060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography.
    Mielke MM; Hagen CE; Xu J; Chai X; Vemuri P; Lowe VJ; Airey DC; Knopman DS; Roberts RO; Machulda MM; Jack CR; Petersen RC; Dage JL
    Alzheimers Dement; 2018 Aug; 14(8):989-997. PubMed ID: 29626426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Nanoplasmonic Biosensor for Ultrasensitive Detection of Alzheimer's Disease Biomarker Using a Chaotropic Agent.
    Kim H; Lee JU; Kim S; Song S; Sim SJ
    ACS Sens; 2019 Mar; 4(3):595-602. PubMed ID: 30747516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A
    Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients.
    Shekhar S; Kumar R; Rai N; Kumar V; Singh K; Upadhyay AD; Tripathi M; Dwivedi S; Dey AB; Dey S
    PLoS One; 2016; 11(7):e0159099. PubMed ID: 27459603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer's disease screening and staging.
    Jiang Y; Zhou X; Ip FC; Chan P; Chen Y; Lai NCH; Cheung K; Lo RMN; Tong EPS; Wong BWY; Chan ALT; Mok VCT; Kwok TCY; Mok KY; Hardy J; Zetterberg H; Fu AKY; Ip NY
    Alzheimers Dement; 2022 Jan; 18(1):88-102. PubMed ID: 34032364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's Disease Plasma Biomarkers Distinguish Clinical Diagnostic Groups in Memory Clinic Patients.
    Gerards M; Schild AK; Meiberth D; Rostamzadeh A; Vehreschild JJ; Wingen-Heimann S; Johannis W; Martino Adami P; Onur OA; Ramirez A; Karikari TK; Ashton NJ; Zetterberg H; Blennow K; Maier F; Jessen F
    Dement Geriatr Cogn Disord; 2022; 51(2):182-192. PubMed ID: 35504263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.
    Janelidze S; Mattsson N; Palmqvist S; Smith R; Beach TG; Serrano GE; Chai X; Proctor NK; Eichenlaub U; Zetterberg H; Blennow K; Reiman EM; Stomrud E; Dage JL; Hansson O
    Nat Med; 2020 Mar; 26(3):379-386. PubMed ID: 32123385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment.
    Kivisäkk P; Carlyle BC; Sweeney T; Trombetta BA; LaCasse K; El-Mufti L; Tuncali I; Chibnik LB; Das S; Scherzer CR; Johnson KA; Dickerson BC; Gomez-Isla T; Blacker D; Oakley DH; Frosch MP; Hyman BT; Aghvanyan A; Bathala P; Campbell C; Sigal G; Stengelin M; Arnold SE
    Front Neurol; 2023; 14():1069411. PubMed ID: 36937522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.